Please assess the completion status of the following clinical trial:

Trial Title: Asthma/Steroid Withdrawal Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Non-smoker (less than 1 pack-year).~2. Age greater than 18 years old.~3. Ability to obtain informed consent.~4. Pulmonary Function Tests demonstrating greater than 12% FEV1 reversibility following beta agonist OR a methacholine challenge consistent with airways hyper-reactivity.~5. Evidence of atopy on standardized skin test battery.~6. Mild to moderate persistent asthma classification by GINA guidelines.~7. No severe exacerbations in the preceding 3 months (defined as emergency room visit, course of oral prednisone or hospitalization).~8. Access to internet.~Exclusion Criteria:~1. Unstable asthma.~2. Patient not on inhaled corticosteroids.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).